Tissue characterization and calcification potential of commercial bioprosthetic heart valves

被引:72
作者
Cunanan, CM
Cabiling, CM
Dinh, TT
Shen, SH
Tran-Hata, P
Rutledge, JH
Fishbein, MC
机构
[1] Edwards Lifesci, Heart Valve Therapy Res, Irvine, CA 92614 USA
[2] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/S0003-4975(01)02493-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Tissue properties may contribute to intrinsic calcification of bioprosthetic heart valves. Phospholipids have been proposed as potential nucleation sites for calcification. Other tissue properties might also be important in calcification. Methods. Commercial and control bioprosthetic valve tissues were characterized by shrinkage temperature, moisture content, free amine content, phospholipid content, and calcification level after 90-day rat subcutaneous implantation as described. Results. Shrinkage temperature, moisture content, and free amine content were typical for glutaraldehyde-cross-linked tissues. Phospholipid and calcium levels varied considerably among valve types. There was a significant correlation between phospholipid levels and calcification (r = 0.63, p = 0.04). Sulzer Carbomedics Mitroflow and Toronto SPV valve tissues had significantly more calcification than other commercial bioprostheses in this study (p < 0.01). Carpentier-Edwards Duraflex, CE SAV, and CE PERIMOUNT valve tissues had significantly less calcification than Medtronic Mosaic in this animal model (p < 0.02). Conclusions. Processes that reduce phospholipid levels are associated with reduced calcification in the rat subcutaneous model. Significant differences in calcification level were found among commercially available valves. The clinical significance of these results is unknown. (C) 2001 by The Society of Thoracic Surgeons.
引用
收藏
页码:S417 / S421
页数:5
相关论文
共 15 条
[1]  
CARPENTIER A, 1984, CIRCULATION, V70, P165
[2]   EFFECT OF 2-AMINO OLEIC-ACID EXPOSURE CONDITIONS ON THE INHIBITION OF CALCIFICATION OF GLUTARALDEHYDE CROSS-LINKED PORCINE AORTIC VALVES [J].
CHEN, WL ;
KIM, JD ;
SCHOEN, FJ ;
LEVY, RJ .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (12) :1485-1495
[3]  
DUGAN EA, 1985, J LIQ CHROMATOGR, V3, P126
[4]   PATHOLOGY OF BIOPROSTHETIC CARDIAC VALVES [J].
FERRANS, VJ ;
TOMITA, Y ;
HILBERT, SL ;
JONES, M ;
ROBERTS, WC .
HUMAN PATHOLOGY, 1987, 18 (06) :586-595
[5]   EFFECT OF AOA ON GLUTARALDEHYDE-FIXED BIOPROSTHETIC HEART-VALVE CUSPS AND WALLS - BINDING AND CALCIFICATION STUDIES [J].
GIRARDOT, MN ;
TORRIANNI, M ;
GIRARDOT, JMD .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (02) :76-82
[6]  
GRABENWOGER M, 1992, J THORAC CARDIOV SUR, V104, P14
[7]  
GRIMM M, 1992, SURGERY, V111, P74
[8]   THE PHOSPHATIDYLINOSITOL-GLYCOLIPID ANCHOR ON ALKALINE-PHOSPHATASE FACILITATES MINERALIZATION INITIATION IN-VITRO [J].
HARRISON, G ;
SHAPIRO, IM ;
GOLUB, EE .
JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 (04) :568-573
[9]   INHIBITION OF BOVINE PERICARDIUM CALCIFICATION - A COMPARATIVE-STUDY OF AL-3+ AND LIPID REMOVING TREATMENTS [J].
HERRERO, EJ ;
GUTIERREZ, MP ;
ESCUDERO, C ;
CASTILLOOLIVARES, JL .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1991, 2 (02) :86-88
[10]  
LENTZ DJ, 1982, CARDIAC BIOPROSTHESE, P306